A Mental Health Renaissance May Soon Disrupt a $225 Billion U.S. Marketplace!
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Unsubscribe
The Seed Investor
A Mental Health Renaissance May Soon Disrupt a $225 Billion U.S. Marketplace!
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 
 
 
A Massive Market Trend Is Forming in Psychoactive Drug Therapies!
 
Emerging biotechs are researching once forbidden drugs to solve some of the most vexing medical problems...those of mental health.

Major investors have launched this sector with over a half-billion dollars in start-up capitalization and they’re already seeing substantial returns!

This trend is just getting started!

Forbes reports that the emerging market in new psychoactive mental health medications... “could bring in a whopping $6.85 billion by 2027.”1

We are Now Entering Phase Two of a Pharmaceutical Renaissance

Research is mounting. An entirely new class of psychoactive medications is showing profound efficacy in treating mental disorders and traumatic brain injuries.
This is cutting edge medical science that has been buried for decades by out-of-date taboos. But times are changing.

Findings are that once-forbidden psycho-active compounds now being extracted from organic sources hold significant promise for treating, even curing mental disorders and injuries once thought to be incurable.

Legal restrictions formerly kept these compounds out of the lab, their benefits remained clouded in secrecy. Now those secrets are coming to light and it appears clear to many that was a HUGE missed opportunity.

The market for psychoactive medicines and drug therapies could accelerate many times faster than what investors anticipated from the cannabis market.

This projected market growth can be expected to drive innovative, start-up biotech companies to rapid growth over the coming months. Some early starters have already achieved significant growth as eager investors rushed to establish ground floor positions.

What’s compelling is that those ground-floor positions have been launched by high-net-worth investors that now fuel the trajectory of this soaring market trend.

WE HAVE SPECIAL ACCESS FOR OUR SUBSCRIBERS TO READ THE FULL REPORT ON THIS GROUND FLOOR OPPORTUNITY
 
 

 

Source: 
1. 
https://www.forbes.com/sites/irisdorbian/2021/01/21/why-investors-are-bullish-about-psychedelics/?sh=791eb9c31a41

 

THIS IS A PAID ADVERTISEMENT: Sandstone Media has agreed to pay Moskowitz $27,500 dollars in cash from the amount it has received from Mind Cure. 

 
 
 
 
Dynamic Wealth Publishing LLC
2010 West Avenue K #623
Lancaster, CA 93536



DWR Disclosure
 
 
 
©2021, All Rights Reserved
 
 
Unsubscribe
 
The Seed Investor, a general interest website and newsletter is not liable for the suitability of future investment performance of any securities or strategies discussed. Please note that we are not registered investment firm or broker/dealer. Only a registered broker or investment adviser may advise you individually on the suitability and performance of your portfolio or specific investments. 

Readers are advised that the material contained herein should be used solely for informational purposes. As a publisher of a financial website of general and regular circulation, we cannot tender individual investment advice. We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

We will not be liable for any loss or damage caused by a reader’s reliance on information obtained on our web sites. Our readers are solely responsible for their own investment decisions. Historical investment return examples given are hypothetical, and not to be taken as representative of any individual’s actual trading experience. Please click here to see our Details and Disclosures. 
 
 
32x32x1   32x32x2  
 
TheSeedInvestor.com
9375 East Shea Boulevard  100
Scottsdale, AZ 85260
 
©2021, All Rights Reserved
Unsubscribe